COMMUNIQUÉS West-GlobeNewswire

Capsa Healthcare Unveils the NEW Kirby Lester KL1v: The Future of Prescription Counting

08/01/2025 - 15:12

A Media Snippet accompanying this announcement is available by clicking on this link. COLUMBUS, Ohio, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in purposefully designed integrated solutions for [...]

Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment

08/01/2025 - 15:15

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMD Access the segment here ISELIN, N.J., Jan. 08, 2025 (GLOBE [...]

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

08/01/2025 - 15:50

Last patient completed 1 year follow-up of study ALA-BCC-CT013 in December 2024. Data from follow-up will be included in FDA submission, expected in Q3 2025. Biofrontera announced highly statistically significant [...]

AdhereTech Announces Appointment of Dean McAlister to Board of Directors

08/01/2025 - 16:00

Life sciences industry veteran brings strong strategic and operational expertise SUMMIT, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) -- AdhereTech, Inc., the market-leading provider of real-time medication adherence solutions [...]

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

08/01/2025 - 16:00

Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology (“Primo”) today announced [...]

MYOS Corp. Encourages Partnering with Pets for Muscle Health and Longevity

08/01/2025 - 16:23

CEDAR KNOLLS, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) -- MYOS Corp ., a leader in proactive muscle health supplements, encourages partnering with your pet to achieve shared longevity and muscle health goals. As cutting- [...]

“Medical Travel Month” January 2025 Sponsored by Medical Travel & Digital Health News in SHSMD American Hospital Association’s Calendar of Health Observances

08/01/2025 - 16:30

OAKLAND, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Medical Travel & Digital Health News (MTDHN) , the leading bi-monthly online newsletter covering the business of medical travel and digital solutions worldwide, today [...]

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

08/01/2025 - 17:00

Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San Francisco Union Square NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ), a specialty biotechnology [...]

Rapafusyn Pharmaceuticals to Showcase Its Molecular Glue Drug Discovery Platform at WuXi Global Forum

08/01/2025 - 17:00

BALTIMORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi Global Forum on [...]

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

08/01/2025 - 13:05

BOSTON and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are [...]

Arch Biopartners Announces Ontario Research Ethics Board Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

08/01/2025 - 13:25

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network Research Ethics Board, through the [...]

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

08/01/2025 - 13:30

- Solnerstotug (SNS-101) dose expansion arm anticipated to be fully enrolled by end of Q1 2025 - - Clinical data update expected in Q2 2025 - BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. ( [...]

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

08/01/2025 - 13:30

– Fourth quarter revenue growth estimated at 105% to 110% year-over-year – – Company to start reporting in accordance with U.S. GAAP and filing with the SEC on U.S. domestic forms – – Profound reminds investors that it [...]

Angitia Biopharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08/01/2025 - 13:30

WOODLAND HILLS, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a global, clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious [...]

BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference

08/01/2025 - 13:30

PALO ALTO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that co- [...]

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

08/01/2025 - 13:30

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of [...]

Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08/01/2025 - 13:30

CHARLOTTE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43 rd Annual J.P. Morgan Healthcare [...]

Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease

08/01/2025 - 13:30

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) patients AER-01-002 is well powered to determine if 28-days of once daily [...]

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

08/01/2025 - 13:30

23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- [...]